• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Engelhard Corporation

Engelhard Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Tennant Company Reports 2017 First Quarter Results

    Tennant Company Reports 2017 First Quarter Results

  2. EOS imaging Announces Opening of First Two EOS® Systems in China

    EOS imaging Announces Opening of First Two EOS® Systems in China

  3. Total Gabon Exercises Its Pre-Emption Rights on the Baudroie-Mérou License

    Total Gabon Exercises Its Pre-Emption Rights on the Baudroie-Mérou License

  4. Biogen’s SPINRAZA® (nusinersen) Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy

    Biogen’s SPINRAZA® (nusinersen) Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy

  5. Xenetic Biosciences’ PolyXen™ Platform Technology Accepted for Poster Presentation at the 13th Annual Protein Engineering Summit (PEGS) Boston

    Xenetic Biosciences’ PolyXen™ Platform Technology Accepted for Poster Presentation at the 13th Annual Protein Engineering Summit (PEGS) Boston

  6. CORRECTING and REPLACING GenMark Achieves CE Mark for its ePlex® Blood Culture Identification Fungal Pathogen Panel

    CORRECTING and REPLACING GenMark Achieves CE Mark for its ePlex® Blood Culture Identification Fungal Pathogen Panel

  7. Twenty-First Century Fox Inc EC clearance for -2-

    Twenty-First Century Fox Inc EC clearance for -2-

  8. Twenty-First Century Fox Inc EC clearance for proposed acquisition of Sky

    Twenty-First Century Fox Inc EC clearance for proposed acquisition of Sky

  9. Recommended Offer for Innocoll Holdings PLC by Gurnet Point L.P. Acting Through Its General Partner Waypoint International GP LLC

    Recommended Offer for Innocoll Holdings PLC by Gurnet Point L.P. Acting Through Its General Partner Waypoint International GP LLC

  10. EOS Imaging Reports 34% Revenue Growth for the First Quarter of 2017

    EOS Imaging Reports 34% Revenue Growth for the First Quarter of 2017

1234

©2017 Morningstar Advisor. All right reserved.